Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Drug produces mixed results in myelofibrosis

    Author:
    HT Staff
    Publish date: November 18, 2016

    Two phase 3 trials have shown mixed results in myelofibrosis (MF) patients receiving the JAK inhibitor momelotinib, according to Gilead Sciences,...

    • Read More

    News

    AACN releases updated resource on VTE

    Author:
    HT Staff
    Publish date: November 18, 2016

    caring for a patient in an intensive care unit The American Association of Critical-Care Nurses (AACN) has released updated resources aimed at...

    • Read More

    News

    Eligible patients aren’t receiving anticoagulants

    Author:
    HT Staff
    Publish date: November 18, 2016

    NEW ORLEANS—Many US patients who are candidates for treatment with oral anticoagulants (OACs) are not actually receiving these drugs, a large...

    • Read More

    News

    Biomaterial stops bleeding, doesn’t rely on thrombosis

    Author:
    HT Staff
    Publish date: November 17, 2016

    Photo courtesy of USDA Bioengineers have developed an injectable material that may provide a better way to stop bleeding in injured patients,...

    • Read More

    News

    Device provides long-lasting drug delivery

    Author:
    HT Staff
    Publish date: November 17, 2016

    with 6 arms that can be folded and encased in a capsule. Photo by Melanie Gonick/MIT A new device can provide long-term, controlled drug release...

    • Read More

    News

    Compound could treat leukemia, other cancers

    Author:
    HT Staff
    Publish date: November 17, 2016

    and Patrick Harran with a model of DZ-2384 Photo courtesy of Reed Hutchinson/UCLA A new compound holds promise for treating leukemia and other...

    • Read More

    News

    Anticoagulant therapies appear comparable

    Author:
    HT Staff
    Publish date: November 17, 2016

    Photo from Business Wire NEW ORLEANS—Two types of anticoagulant therapy produce comparable outcomes for patients undergoing percutaneous coronary...

    • Read More

    News

    Hemophilia treatment falling short, study suggests

    Author:
    HT Staff
    Publish date: November 16, 2016

    Results of a real-world, retrospective study suggest there may be a need to improve the standard of care for hemophilia A and B in some European...

    • Read More

    News

    Company withdraws application for eryaspase in ALL

    Author:
    HT Staff
    Publish date: November 16, 2016

    The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) asked for additional data on eryaspase, but ERYTECH...

    • Read More

    News

    Study shows lower bleeding risk with rivaroxaban

    Author:
    HT Staff
    Publish date: November 16, 2016

    NEW ORLEANS—Results of the PIONEER AF-PCI trial suggest certain patients may have a lower risk of bleeding if they receive rivaroxaban rather than...

    • Read More

    News

    Team develops model of common infant ALL

    Author:
    HT Staff
    Publish date: November 16, 2016

    Photo by Petr Kratochvil After trying for nearly 2 decades, researchers have created a mouse model of t(4;11) pro-B acute lymphoblastic leukemia...

    • Read More

    News

    Antiplatelet drugs produce similar results in PAD

    Author:
    HT Staff
    Publish date: November 15, 2016

    Photo from AstraZeneca NEW ORLEANS—Results of the EUCLID trial suggest ticagrelor does not a provide a benefit over clopidogrel in patients with...

    • Read More

    News

    EMA recommends orphan status for drug in AML

    Author:
    HT Staff
    Publish date: November 15, 2016

    The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that BP1001 receive orphan designation as a...

    • Read More

    News

    FDA grants priority review for midostaurin

    Author:
    HT Staff
    Publish date: November 15, 2016

    The US Food and Drug Administration (FDA) has granted priority review for the new drug application for midostaurin (PKC412) as a treatment for...

    • Read More

    News

    MRI detects early stages of MF in mice

    Author:
    HT Staff
    Publish date: November 15, 2016

    Magnetic resonance imaging (MRI) can effectively detect myelofibrosis (MF) in a mouse model, according to research published in the journal Blood...

    • Read More

    Pages

    • « first
    • …
    • 86
    • 87
    • 88
    • 89
    • 90
    • 91
    • 92
    • 93
    • 94
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery